WHO Working Group meeting on standardization of acellular pertussis vaccines: Potency assay. Beijing, China, 7-9 November 2007

Vaccine

Volumn 26, Issue 32, 2008, Pages 3960-3968

  Knezevic, I ^a   Baca Estrada, M ^b   Xing, D K ^c   Lei, D ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b HEALTH CANADA   (Canada)

^c NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Acellular pertussis vaccines; International Standard; WHO

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; PERTUSSIS VACCINE;

CHINA; CONFERENCE PAPER; DRUG APPROVAL; DRUG EFFICACY; DRUG QUALITY; GOOD MANUFACTURING PRACTICE; HUMAN; JAPAN; KOREA; NONHUMAN; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; STANDARDIZATION; TOXICITY TESTING; VACCINE PRODUCTION; WORLD HEALTH ORGANIZATION;

BIOLOGICAL ASSAY; CHINA; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GUIDELINES AS TOPIC; HUMANS; PERTUSSIS VACCINE; QUALITY CONTROL; REFERENCE STANDARDS; VACCINES, ACELLULAR; WHOOPING COUGH; WORLD HEALTH ORGANIZATION;

EID: 47149100690     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.04.064     Document Type: Conference Paper

References (10)

1. Xing D.K.L., Corbel M., Dobbelaer R., and Knezevic I. WHO Working Group on standardization and control of acellular pertussis vaccines-report of a meeting held on 16-17 March 2006, St. Albans, United Kingdom. Vaccine 25 (2007) 2749-2757
2. Guidelines for the production and control of the acellular pertussis component of monovalent or combined vaccines. In: WHO Expert Committee on Biological Standardization. Forty-seventh report. World Health Organization: Geneva; 1998 [(WHO Technical Report Series, no. 878), Annex 2].
3. Milstien J., Dellepiane N., Lambert S., Belgharbi L., Rolls C., Knezevic I., et al. Vaccine quality-can a single standard be defined?. Vaccine 20 January (7-8) (2002) 1000-1003
4. Corbel M.J., Kreeftenberg J.G., and Knezevic I. WHO Working Group on the standardisation and control of pertussis vaccines-report of a meeting held on 6-7 May 2003, Ferney-Voltaire, France. Vaccine 22 (2004) 293-300
5. Corbel M.J., Mastrantonio P., and Kreeftenberg J.G. Ad Hoc Working Group on acellular pertussis vaccines, World Health Organisation, Geneva, 27-28 July 2000. Vaccine 20 (2002) 288-291
6. Corbel MJ, Xing DKL, Kreeftenberg JG. Informal consultation with manufacturers and WHO Ad Hoc Working Group on mouse protection models for acellular pertussis vaccines. Meeting report. Biologicals 1999;27:189-93.
7. Isomura S. Clinical studies on efficacy and safety of acellular pertussis vaccine. Tokai J. Exp. Clin. Med. Suppl. 13 (1988) 39-43
8. Pillemer L. Protective antigen of Haemophilus pertussis. Lancet 1 (1954) 1257-1260
9. David S., van Furth R., and Mooi F.R. Vaccine 22 May (15-16) (2004) 1892-1898
10. Van den Berg B.M., Beekhuizen H., Mooi F.R., and van Furth R. Infect. Immun. 67 March (3) (1999) 1050-1055